Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Update on the use of hydroxyurea therapy in sickle cell disease. Blood 2014 Dec 18;124(26):3850-7; quiz 4004

Date

10/08/2014

Pubmed ID

25287707

Pubmed Central ID

PMC4271176

DOI

10.1182/blood-2014-08-435768

Scopus ID

2-s2.0-84919464653 (requires institutional sign-in at Scopus site)   82 Citations

Author List

Wong TE, Brandow AM, Lim W, Lottenberg R

Author

Amanda Brandow DO Professor in the Pediatrics department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adult
Anemia, Sickle Cell
Anti-Inflammatory Agents, Non-Steroidal
Antisickling Agents
Child, Preschool
Female
Hospitalization
Humans
Hydroxyurea
Male
Observational Studies as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
Young Adult
beta-Thalassemia